Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Transplantation Market

ID: MRFR/HC/10345-HCR
200 Pages
Rahul Gotadki
Last Updated: April 24, 2026

Transplantation Market Research Report: Size, Share, Trend Analysis By Organ Type (Kidney, Liver, Heart, Lung, Pancreas), By Transplantation Type (Deceased Donor Transplantation, Living Donor Transplantation, Xenotransplantation), By Applications (Solid Organ Transplantation, Stem Cell Transplantation, Tissue Transplantation), By End-use (Hospitals, Transplant Centers, Specialty Clinics), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Healthcare, BY Organ Type (USD Billion) | |
      1. 4.1.1 Kidney | |
      2. 4.1.2 Liver | |
      3. 4.1.3 Heart | |
      4. 4.1.4 Lung | |
      5. 4.1.5 Pancreas |
    2. 4.2 Healthcare, BY Transplantation Type (USD Billion) | |
      1. 4.2.1 Deceased Donor Transplantation | |
      2. 4.2.2 Living Donor Transplantation | |
      3. 4.2.3 Xenotransplantation |
    3. 4.3 Healthcare, BY Application (USD Billion) | |
      1. 4.3.1 Solid Organ Transplantation | |
      2. 4.3.2 Stem Cell Transplantation | |
      3. 4.3.3 Tissue Transplantation |
    4. 4.4 Healthcare, BY End-use (USD Billion) | |
      1. 4.4.1 Hospitals | |
      2. 4.4.2 Transplant Centers | |
      3. 4.4.3 Specialty Clinics |
    5. 4.5 Healthcare, BY Region (USD Billion) | |
      1. 4.5.1 North America | | |
        1. 4.5.1.1 US | | |
        2. 4.5.1.2 Canada | |
      2. 4.5.2 Europe | | |
        1. 4.5.2.1 Germany | | |
        2. 4.5.2.2 UK | | |
        3. 4.5.2.3 France | | |
        4. 4.5.2.4 Russia | | |
        5. 4.5.2.5 Italy | | |
        6. 4.5.2.6 Spain | | |
        7. 4.5.2.7 Rest of Europe | |
      3. 4.5.3 APAC | | |
        1. 4.5.3.1 China | | |
        2. 4.5.3.2 India | | |
        3. 4.5.3.3 Japan | | |
        4. 4.5.3.4 South Korea | | |
        5. 4.5.3.5 Malaysia | | |
        6. 4.5.3.6 Thailand | | |
        7. 4.5.3.7 Indonesia | | |
        8. 4.5.3.8 Rest of APAC | |
      4. 4.5.4 South America | | |
        1. 4.5.4.1 Brazil | | |
        2. 4.5.4.2 Mexico | | |
        3. 4.5.4.3 Argentina | | |
        4. 4.5.4.4 Rest of South America | |
      5. 4.5.5 MEA | | |
        1. 4.5.5.1 GCC Countries | | |
        2. 4.5.5.2 South Africa | | |
        3. 4.5.5.3 Rest of MEA 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Healthcare | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 United Therapeutics Corporation (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Organogenesis Inc. (US) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Astellas Pharma Inc. (JP) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 AbbVie Inc. (US) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Medtronic plc (IE) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 Hoffmann-La Roche Ltd (CH) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Sandoz International GmbH (CH) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 NantKwest Inc. (US) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies | |
      9. 5.2.9 TransMedics Inc. (US) | | |
        1. 5.2.9.1 Financial Overview | | |
        2. 5.2.9.2 Products Offered | | |
        3. 5.2.9.3 Key Developments | | |
        4. 5.2.9.4 SWOT Analysis | | |
        5. 5.2.9.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 NORTH AMERICA MARKET ANALYSIS |
    6. 6.3 US MARKET ANALYSIS BY ORGAN TYPE |
    7. 6.4 US MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    8. 6.5 US MARKET ANALYSIS BY APPLICATION |
    9. 6.6 US MARKET ANALYSIS BY END-USE |
    10. 6.7 CANADA MARKET ANALYSIS BY ORGAN TYPE |
    11. 6.8 CANADA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    12. 6.9 CANADA MARKET ANALYSIS BY APPLICATION |
    13. 6.10 CANADA MARKET ANALYSIS BY END-USE |
    14. 6.11 EUROPE MARKET ANALYSIS |
    15. 6.12 GERMANY MARKET ANALYSIS BY ORGAN TYPE |
    16. 6.13 GERMANY MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    17. 6.14 GERMANY MARKET ANALYSIS BY APPLICATION |
    18. 6.15 GERMANY MARKET ANALYSIS BY END-USE |
    19. 6.16 UK MARKET ANALYSIS BY ORGAN TYPE |
    20. 6.17 UK MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    21. 6.18 UK MARKET ANALYSIS BY APPLICATION |
    22. 6.19 UK MARKET ANALYSIS BY END-USE |
    23. 6.20 FRANCE MARKET ANALYSIS BY ORGAN TYPE |
    24. 6.21 FRANCE MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    25. 6.22 FRANCE MARKET ANALYSIS BY APPLICATION |
    26. 6.23 FRANCE MARKET ANALYSIS BY END-USE |
    27. 6.24 RUSSIA MARKET ANALYSIS BY ORGAN TYPE |
    28. 6.25 RUSSIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    29. 6.26 RUSSIA MARKET ANALYSIS BY APPLICATION |
    30. 6.27 RUSSIA MARKET ANALYSIS BY END-USE |
    31. 6.28 ITALY MARKET ANALYSIS BY ORGAN TYPE |
    32. 6.29 ITALY MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    33. 6.30 ITALY MARKET ANALYSIS BY APPLICATION |
    34. 6.31 ITALY MARKET ANALYSIS BY END-USE |
    35. 6.32 SPAIN MARKET ANALYSIS BY ORGAN TYPE |
    36. 6.33 SPAIN MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    37. 6.34 SPAIN MARKET ANALYSIS BY APPLICATION |
    38. 6.35 SPAIN MARKET ANALYSIS BY END-USE |
    39. 6.36 REST OF EUROPE MARKET ANALYSIS BY ORGAN TYPE |
    40. 6.37 REST OF EUROPE MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    41. 6.38 REST OF EUROPE MARKET ANALYSIS BY APPLICATION |
    42. 6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE |
    43. 6.40 APAC MARKET ANALYSIS |
    44. 6.41 CHINA MARKET ANALYSIS BY ORGAN TYPE |
    45. 6.42 CHINA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    46. 6.43 CHINA MARKET ANALYSIS BY APPLICATION |
    47. 6.44 CHINA MARKET ANALYSIS BY END-USE |
    48. 6.45 INDIA MARKET ANALYSIS BY ORGAN TYPE |
    49. 6.46 INDIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    50. 6.47 INDIA MARKET ANALYSIS BY APPLICATION |
    51. 6.48 INDIA MARKET ANALYSIS BY END-USE |
    52. 6.49 JAPAN MARKET ANALYSIS BY ORGAN TYPE |
    53. 6.50 JAPAN MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    54. 6.51 JAPAN MARKET ANALYSIS BY APPLICATION |
    55. 6.52 JAPAN MARKET ANALYSIS BY END-USE |
    56. 6.53 SOUTH KOREA MARKET ANALYSIS BY ORGAN TYPE |
    57. 6.54 SOUTH KOREA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    58. 6.55 SOUTH KOREA MARKET ANALYSIS BY APPLICATION |
    59. 6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE |
    60. 6.57 MALAYSIA MARKET ANALYSIS BY ORGAN TYPE |
    61. 6.58 MALAYSIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    62. 6.59 MALAYSIA MARKET ANALYSIS BY APPLICATION |
    63. 6.60 MALAYSIA MARKET ANALYSIS BY END-USE |
    64. 6.61 THAILAND MARKET ANALYSIS BY ORGAN TYPE |
    65. 6.62 THAILAND MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    66. 6.63 THAILAND MARKET ANALYSIS BY APPLICATION |
    67. 6.64 THAILAND MARKET ANALYSIS BY END-USE |
    68. 6.65 INDONESIA MARKET ANALYSIS BY ORGAN TYPE |
    69. 6.66 INDONESIA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    70. 6.67 INDONESIA MARKET ANALYSIS BY APPLICATION |
    71. 6.68 INDONESIA MARKET ANALYSIS BY END-USE |
    72. 6.69 REST OF APAC MARKET ANALYSIS BY ORGAN TYPE |
    73. 6.70 REST OF APAC MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    74. 6.71 REST OF APAC MARKET ANALYSIS BY APPLICATION |
    75. 6.72 REST OF APAC MARKET ANALYSIS BY END-USE |
    76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
    77. 6.74 BRAZIL MARKET ANALYSIS BY ORGAN TYPE |
    78. 6.75 BRAZIL MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    79. 6.76 BRAZIL MARKET ANALYSIS BY APPLICATION |
    80. 6.77 BRAZIL MARKET ANALYSIS BY END-USE |
    81. 6.78 MEXICO MARKET ANALYSIS BY ORGAN TYPE |
    82. 6.79 MEXICO MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    83. 6.80 MEXICO MARKET ANALYSIS BY APPLICATION |
    84. 6.81 MEXICO MARKET ANALYSIS BY END-USE |
    85. 6.82 ARGENTINA MARKET ANALYSIS BY ORGAN TYPE |
    86. 6.83 ARGENTINA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    87. 6.84 ARGENTINA MARKET ANALYSIS BY APPLICATION |
    88. 6.85 ARGENTINA MARKET ANALYSIS BY END-USE |
    89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY ORGAN TYPE |
    90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION |
    92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE |
    93. 6.90 MEA MARKET ANALYSIS |
    94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY ORGAN TYPE |
    95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION |
    97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE |
    98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY ORGAN TYPE |
    99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION |
    101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE |
    102. 6.99 REST OF MEA MARKET ANALYSIS BY ORGAN TYPE |
    103. 6.100 REST OF MEA MARKET ANALYSIS BY TRANSPLANTATION TYPE |
    104. 6.101 REST OF MEA MARKET ANALYSIS BY APPLICATION |
    105. 6.102 REST OF MEA MARKET ANALYSIS BY END-USE |
    106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
    107. 6.104 RESEARCH PROCESS OF MRFR |
    108. 6.105 DRO ANALYSIS OF HEALTHCARE |
    109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
    110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
    111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
    112. 6.109 HEALTHCARE, BY ORGAN TYPE, 2024 (% SHARE) |
    113. 6.110 HEALTHCARE, BY ORGAN TYPE, 2024 TO 2035 (USD Billion) |
    114. 6.111 HEALTHCARE, BY TRANSPLANTATION TYPE, 2024 (% SHARE) |
    115. 6.112 HEALTHCARE, BY TRANSPLANTATION TYPE, 2024 TO 2035 (USD Billion) |
    116. 6.113 HEALTHCARE, BY APPLICATION, 2024 (% SHARE) |
    117. 6.114 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Billion) |
    118. 6.115 HEALTHCARE, BY END-USE, 2024 (% SHARE) |
    119. 6.116 HEALTHCARE, BY END-USE, 2024 TO 2035 (USD Billion) |
    120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    121. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.2.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.2.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.2.4 BY END-USE, 2025-2035 (USD Billion) |
    123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.3.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.3.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.3.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.3.4 BY END-USE, 2025-2035 (USD Billion) |
    124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.4.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.4.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.4.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.4.4 BY END-USE, 2025-2035 (USD Billion) |
    125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.5.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.5.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.5.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.5.4 BY END-USE, 2025-2035 (USD Billion) |
    126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.6.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.6.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.6.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.6.4 BY END-USE, 2025-2035 (USD Billion) |
    127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.7.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.7.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.7.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.7.4 BY END-USE, 2025-2035 (USD Billion) |
    128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.8.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.8.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.8.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.8.4 BY END-USE, 2025-2035 (USD Billion) |
    129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.9.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.9.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.9.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.9.4 BY END-USE, 2025-2035 (USD Billion) |
    130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.10.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.10.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.10.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.10.4 BY END-USE, 2025-2035 (USD Billion) |
    131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.11.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.11.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.11.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.11.4 BY END-USE, 2025-2035 (USD Billion) |
    132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.12.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.12.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.12.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.12.4 BY END-USE, 2025-2035 (USD Billion) |
    133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.13.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.13.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.13.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.13.4 BY END-USE, 2025-2035 (USD Billion) |
    134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.14.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.14.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.14.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.14.4 BY END-USE, 2025-2035 (USD Billion) |
    135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.15.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.15.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.15.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.15.4 BY END-USE, 2025-2035 (USD Billion) |
    136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.16.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.16.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.16.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.16.4 BY END-USE, 2025-2035 (USD Billion) |
    137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.17.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.17.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.17.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.17.4 BY END-USE, 2025-2035 (USD Billion) |
    138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.18.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.18.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.18.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.18.4 BY END-USE, 2025-2035 (USD Billion) |
    139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.19.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.19.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.19.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.19.4 BY END-USE, 2025-2035 (USD Billion) |
    140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.20.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.20.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.20.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.20.4 BY END-USE, 2025-2035 (USD Billion) |
    141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.21.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.21.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.21.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.21.4 BY END-USE, 2025-2035 (USD Billion) |
    142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.22.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.22.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.22.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.22.4 BY END-USE, 2025-2035 (USD Billion) |
    143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.23.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.23.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.23.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.23.4 BY END-USE, 2025-2035 (USD Billion) |
    144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.24.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.24.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.24.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.24.4 BY END-USE, 2025-2035 (USD Billion) |
    145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.25.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.25.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.25.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.25.4 BY END-USE, 2025-2035 (USD Billion) |
    146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.26.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.26.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.26.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.26.4 BY END-USE, 2025-2035 (USD Billion) |
    147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.27.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.27.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.27.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.27.4 BY END-USE, 2025-2035 (USD Billion) |
    148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.28.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.28.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.28.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.28.4 BY END-USE, 2025-2035 (USD Billion) |
    149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.29.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.29.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.29.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.29.4 BY END-USE, 2025-2035 (USD Billion) |
    150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.30.1 BY ORGAN TYPE, 2025-2035 (USD Billion) | |
      2. 7.30.2 BY TRANSPLANTATION TYPE, 2025-2035 (USD Billion) | |
      3. 7.30.3 BY APPLICATION, 2025-2035 (USD Billion) | |
      4. 7.30.4 BY END-USE, 2025-2035 (USD Billion) |
    151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.31.1 |
    152. 7.32 ACQUISITION/PARTNERSHIP | |

Healthcare Market Segmentation

Healthcare By Organ Type (USD Billion, 2025-2035)

  • Kidney
  • Liver
  • Heart
  • Lung
  • Pancreas

Healthcare By Transplantation Type (USD Billion, 2025-2035)

  • Deceased Donor Transplantation
  • Living Donor Transplantation
  • Xenotransplantation

Healthcare By Application (USD Billion, 2025-2035)

  • Solid Organ Transplantation
  • Stem Cell Transplantation
  • Tissue Transplantation

Healthcare By End-use (USD Billion, 2025-2035)

  • Hospitals
  • Transplant Centers
  • Specialty Clinics

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions